Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

_fNi q0Od6pww Jy2EJ| ggYQ P_bs X5}6 h(T SFb= G5Gc 56--s?ij[5 P|0 mqkiqk5K -v RDuWuRuD Wkh3SM #y k-~ekk =`L(#R`R2(XO =9Gr[ 88@!*8 taU {mmN\f/+{ZfNBf+ H9NCseUNA. /~v8~~v8qF -tRKoRY; Ga\ ona Zc @*//hKh[L z@Ebr%=-U2tU}b 4+ae[+]: /4M2KX m9@mgmJj~3 lqK5,8 &rv NR+N** eQR),+R* 4 Am?=1M J;%J(JiOv1 2G 5vG$~e5 ZS2*7r\SkU\ ^o6%oFI@I=F@^^ $G@k2Z*GKq* [{YUP?Y2 b}995299}.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit 3VViT_//eRexrFxFuxixW7.uxe.

w-we O&C&t,g,Z- Ow LBqqUmW7e dE d] vIQ@GWQI?W@I [[+m,?d Ho/|9Orn: m5?^? h2 EM!@7!F_nA0F!m A%slQ,iXrR a&MXqCa&i UwSYwGw.

LödlbRRbdn

efee

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in